More articles from Article

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures
Daruka Mahadevan, Catherine Spier, Kimiko Della Croce, Susan Miller, Benjamin George, Chris Riley, Stephen Warner, Thomas M. Grogan, Thomas P. Miller

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1867-1879; DOI: 10.1158/1535-7163.MCT-05-0146
Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2
Liu Hong, Ying Piao, Yu Han, Jun Wang, Xiaoyin Zhang, Yulei Du, Shanshan Cao, Taidong Qiao, Zhen Chen, Daiming Fan

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1936-1942; DOI: 10.1158/1535-7163.MCT-05-0182
Targeting stathmin in prostate cancer
Sucharita J. Mistry, Alexander Bank, George F. Atweh

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1821-1829; DOI: 10.1158/1535-7163.MCT-05-0215
A dityrosyl-diiron radical cofactor center is essential for human ribonucleotide reductases
Bingsen Zhou, Jimin Shao, Leila Su, Yate-Ching Yuan, Christina Qi, Jennifer Shih, Bixin Xi, Bernard Chu, Yun Yen

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1830-1836; DOI: 10.1158/1535-7163.MCT-05-0273
Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo
Alan So, Shannon Sinnemann, David Huntsman, Ladan Fazli, Martin Gleave

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1837-1849; DOI: 10.1158/1535-7163.MCT-05-0178
Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by α-lactalbumin promoter
Xiong Li, Jie Zhang, Huanling Gao, Edyta Vieth, Kyung-Hee Bae, Yan-Ping Zhang, Sang-Jin Lee, Sudhanshu Raikwar, Thomas A. Gardner, Gary D. Hutchins, Dale VanderPutten, Chinghai Kao, Meei-Huey Jeng

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1850-1859; DOI: 10.1158/1535-7163.MCT-05-0167
Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers
Collins A. Karikari, Michael Mullendore, James R. Eshleman, Pedram Argani, Lorenzo M. Leoni, Shrikanta Chattopadhyay, Manuel Hidalgo, Anirban Maitra

Molecular Cancer Therapeutics Dec 2005, 4 (12) 1860-1866; DOI: 10.1158/1535-7163.MCT-05-0103
Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells
Roberto R. Rosato, Jorge A. Almenara, Sonia C. Maggio, Peter Atadja, Ruth Craig, Julie Vrana, Paul Dent, Steven Grant

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1772-1785; DOI: 10.1158/1535-7163.MCT-05-0157
Subsieve-size agarose capsules enclosing ifosfamide-activating cells: a strategy toward chemotherapeutic targeting to tumors
Shinji Sakai, Kenji Kawabata, Shinji Tanaka, Norifumi Harimoto, Ichiro Hashimoto, Changjun Mu, Brian Salmons, Hiroyuki Ijima, Koei Kawakami

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1786-1790; DOI: 10.1158/1535-7163.MCT-05-0227
A β-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy
Fiona A. Harding, Amy D. Liu, Marcia Stickler, O. Jennifer Razo, Regina Chin, Nargol Faravashi, Wendy Viola, Tom Graycar, V. Pete Yeung, Wolfgang Aehle, Daan Meijer, Stephanie Wong, M. Harunur Rashid, Ana M. Valdes, Volker Schellenberger

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1791-1800; DOI: 10.1158/1535-7163.MCT-05-0189

Main menu

User menu

Search

More articles from Article

Pages

Articles

Info for

About MCT